ACADIA PHARMACEUTICALS INC — Director's Dealing 2021

Apr 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2021-04-29

Reporting Person: Stankovic Srdjan R. (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-29	Common Stock	M	9615	—	Acquired	40664	Direct
2021-04-30	Common Stock	S	4230	$20.33	Disposed	36434	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-29	Restricted Stock Units	$	M	9615	Disposed		Common Stock (9615)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.

F2: The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.

F3: The restricted stock units vest in four equal annual installments beginning 4/29/2020.